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Abstract
Objectives To investigate socioeconomic inequalities in outcome of
pregnancy and neonatal mortality associated with congenital anomalies.
Design Retrospective population based registry study.
Setting East Midlands and South Yorkshire regions of England
(representing about 10% of births in England and Wales).
Participants All registered cases of nine selected congenital anomalies
with poor prognostic outcome audited as part of the United Kingdom’s
fetal anomaly screening programme with an end of pregnancy date
between 1 January 1998 and 31 December 2007.
Main outcome measures Socioeconomic variation in the risk of selected
congenital anomalies; outcome of pregnancy; incidence of live birth and
neonatal mortality over time. Deprivation measured with the index of
multiple deprivation 2004 at super output area level.
Results There were 1579 fetuses registered with one of the nine selected
congenital anomalies. There was no evidence of variation in the overall
risk of these anomalies with deprivation (rate ratio for the most deprived
10th with the least deprived 10th: 1.05, 95% confidence interval 0.89 to
1.23). The rate ratio varied with type of anomaly and maternal age
(deprivation rate ratio adjusted for maternal age: 1.43 (1.17 to 1.74) for
non-chromosomal anomalies; 0.85 (0.63 to 1.15) for chromosomal
anomalies). Of the nine anomalies, 86% were detected in the antenatal
period, and there was no evidence that this varied with deprivation (rate
ratio 0.99, 0.84 to 1.17). The rate of termination after antenatal diagnosis
of a congenital anomaly was lower in the most deprived areas compared
with the least deprived areas (63% v 79%; rate ratio 0.80, 0.65 to 0.97).
Consequently there were significant socioeconomic inequalities in the
rate of live birth and neonatal mortality associated with the presence of
any of these nine anomalies. Compared with the least deprived areas,
the most deprived areas had a 61% higher rate of live births (1.61, 1.21
to 2.15) and a 98% higher neonatal mortality rate (1.98, 1.20 to 3.27)
associated with a congenital anomaly.
Conclusions Antenatal screening for congenital anomalies has reduced
neonatal mortality through termination of pregnancy. Socioeconomic
variation in decisions regarding termination of pregnancy after antenatal
detection, however, has resulted in wide socioeconomic inequalities in
liveborn infants with a congenital anomaly and subsequent neonatal
mortality.
Introduction
Congenital anomalies are a major cause of neonatal and infant
mortality, especially in developed countries, accounting for
around 30% of infant deaths in the UK.
1 Furthermore they
explain a quarter of the widening socioeconomic inequality in
neonatal mortality in England.
2 Understanding how these
inequalities relating to congenital anomalies arise is key to
implementing effective public health interventions to reduce
socioeconomic inequalities in infant and neonatal mortality.
Socioeconomic inequalities in congenital anomalies have been
shown to exist in the rates of stillbirth and perinatal, neonatal,
and infant mortality.
1-4 Research has shown an increasing risk
of non-chromosomal anomalies with increasing deprivation
5
and, in contrast, a decreasing risk of chromosomal anomalies,
though this latter finding is predominantly because of the
increased risk of chromosomal anomalies with increasing
maternalage.
5Theinfluenceofsocioeconomicdeprivationalong
the pathway from antenatal detection to delivery and possible
neonatal mortality, however, is not fully understood because of
the lack of rigorous data in the antenatal period. Countries that
have introduced the use of prenatal diagnostic techniques and
access to termination of pregnancy because of congenital
anomalyhaveseenlargereductionsinneonatalmortalityrates,
6-9
unlike those countries with more restrictive policies on
pregnancy termination.
10 Nevertheless, the impact of these
secondarypreventativemeasuresmightvarywithsocioeconomic
deprivation in terms of access to, and timing of, antenatal
detection services through to the provision of information, the
interpretation of risk, and the consequent decision regarding
continuation or termination of a pregnancy.
Evidenceissparse.AsystematicreviewofstudiesintheUnited
Kingdomshowednoevidenceofsocialinequalitiesintheuptake
ofprenatalscreening,
11whileresearchinNorthernIreland,where
access to termination services is much more restricted, showed
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RESEARCHinequalitiesinboththeofferanduptakeofscreening.
11 12Further
research suggests that socioeconomic differentials in decision
making after antenatal detection are because of differences in
maternal age.
13 The term “congenital anomaly” covers a wide
spectrum from the relatively minor to those with an
exceptionally poor prognostic outcome, and it is the latter that
will be most affected by secondary preventative measures.
We used data from a large congenital anomaly register in
England (covering about 10% of the births in England and
Wales)for1998-2007toinvestigatesocioeconomicinequalities
in the risk of congenital anomalies with a poor prognosis from
antenataldiagnosistoendofpregnancy.Weexploredtheimpact
ofvariationsinratesofterminationofpregnancyforcongenital
anomaly on rates of stillbirth, live birth, and neonatal mortality
associated with congenital anomaly to aid understanding of the
reasonsforthewideningsocioeconomicinequalitiesinneonatal
and infant mortality in England.
Methods
Study population
The East Midlands and South Yorkshire (England) congenital
anomaly register (EMSYCAR) currently covers about 74 000
birthsannually(abouta10thofallbirthsinEnglandandWales).
We excluded data for Northamptonshire, which joined the
register in 2003, leaving a geographical area with about 60 000
births annually. This register is population based and includes
allcongenitalanomaliesinfetusesandinfantsofmothersliving
within the region at the time of delivery. It includes live births,
stillbirths (from 24 weeks of gestation), spontaneous fetal loss
(before 24 weeks of gestation), or termination of pregnancy
because of fetal anomaly at any gestational age. The register
uses multiple sources of case ascertainment from within the
care pathway, including antenatal ultrasonography, antenatal
screening, delivery reports, birth notifications, pathology,
cytogenetics, clinical genetics, and paediatric surgery. All
reported anomalies are coded according to the 10th revision of
theinternationalclassificationofdisease(ICD-10).Information
on maternal age and ethnicity, mother’s postcode of residence
at delivery, end date of pregnancy, and gestation at delivery
were available from data collected by the register. We included
in our study fetuses with an anomaly with an end of pregnancy
date between 1 January 1998 and 31 December 2007.
As the focus of our study was how socioeconomic inequalities
arise along the pathway from antenatal detection to delivery,
we selected serious congenital anomalies, which we defined as
eitherincompatiblewithlifeorassociatedwithseveremorbidity
but which also have screening systems in place for a precise
antenatal diagnosis to allow parents to make an informed
decision about continuation of the pregnancy. As a starting
point,wethereforeusedthe11anomaliesidentifiedbythefetal
anomaly screening programme in the UK (see table 1).
14 We
excluded two anomalies—cleft lip and gastroschisis—as they
were much less likely to have a poor prognostic outcome. We
also chose to include only those conditions where the ICD-10
codeuniquelyidentifiedananomalyforwhichtherewasahigh
level of certainty about an adverse prognosis, resulting in nine
anomalies that met these criteria: two chromosomal anomalies
(trisomy 13 and trisomy 18) and seven non-chromosomal
anomalies (anencephaly, spina bifida, hypoplastic left heart,
bilateralrenalagenesis,lethalskeletaldysplasia,diaphragmatic
hernia, and exomphalos). Where fetuses were registered with a
chromosomal diagnosis, we considered any coexisting
congenital anomalies as secondary to the underlying
chromosomal problem, rather than separate non-chromosomal
anomalies,assuchassociationsarewellestablished.Additional
informationonantenataldetectionwasobtainedfromtheregister
on these selected anomalies, including the method and timing
of diagnosis. An anomaly was deemed to be “antenatally
detected” if the date of detection of the exact, or a closely
related, anomaly predated delivery or the date of detection of
an antenatal soft marker related to the anomaly present at
delivery predated the date of delivery.
We obtained denominator data on live birth (from the Office
for National Statistics) and stillbirth (from the Centre for
Maternal and Child Enquiries (CMACE)) by year of birth,
mother’s age, and the 10th of deprivation of the mother’s
residence at the time of birth for the study period (1 January
1998 to 31 December 2007). Deprivation was measured with
an area level measure, the index of multiple deprivation 2004.
15
This measure comprises seven domain indices at the super
output area level, which relate to income deprivation,
employment deprivation, health deprivation and disability,
education, skills and training deprivation, barriers to housing
and services, and living environment deprivation and crime.
Super output areas are the smallest areas for which these
deprivation data are available; although some degree of
heterogeneity will exist within them, the small size of the areas
(only 1500 residents) limits this. We ranked all super output
areas in England by deprivation score and divided them into 10
groupswithaboutequalpopulationsofbirths:1(leastdeprived)
to 10 (most deprived). The geographical area covered by this
study has a slightly more deprived profile compared with
England (see table 2). Ideally analyses would be based on
mother’spostcodeatconception,butthiswasnotavailablefrom
theregister.Analyseswerethereforebasedonmother’spostcode
atdelivery.Toassessthepotentialimpactofchangesinmother’s
residencethroughthepregnancyontheobservedsocioeconomic
inequalities we looked at deprivation at antenatal detection and
delivery for those fetuses where this information was
available—that is, fetuses detected in the antenatal period from
pregnancies that did not end in termination.
Analyseswereundertakenattheindividualcase(fetusorbaby)
level. Poisson regression models
16 were used to assess trends in
the six outcome measures by deprivation 10th over time
(1998-2002; 2003-7):
• Rate of selected anomalies in utero (all cases of selected
anomalies whether identified in the antenatal period or at
birth)(denominator:totallivebirths,stillbirths,andknown
late fetal losses and terminations of pregnancy—that is,
those registered with a fetal anomaly)
• Rate of antenatal detection (denominator: all cases of
selected anomalies)
• Rateofterminationofpregnancybecauseoffetalanomaly
(denominator: antenatally detected cases)
• Rate of fetal loss or stillbirth with an anomaly
(denominator: total live births, stillbirths, and known late
fetallosses—thatis,thoseregisteredwithafetalanomaly)
• Rate of live births with an anomaly (denominator: total
live births)
• Rate of neonatal mortality of infants with an anomaly
(denominator: total live births).
Dataonterminatedpregnanciesandfetallossesbefore24weeks’
gestation were available only when they were associated with
a congenital anomaly. Only these terminations and late fetal
losseswereincludedinthedenominatorsforcalculationofrates
of anomalies “in utero.” Models were fitted for all anomalies
combined and then separately for chromosomal and
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assess the change in the effect of deprivation over time. We
then included maternal age (<20, 20-24, 25-29, 30-34, >35) in
the models to assess its influence on any observed
socioeconomicinequality.Confidencelimitswereobtainedwith
the delta method.
17 The numbers of live births and stillbirths
were not available by ethnic group, though ethnic group was
recordedaspartoftheregister(86%complete)andsowecould
exploretheconfoundingeffectofethnicityonratesofantenatal
detection and termination of pregnancy. We included ethnicity
(classifiedintofourgroups:whiteBritish,AsianorAsianBritish
(Indian), Asian or Asian British (Pakistani), and other or
missing)intheregressionmodelstoassesswhethertheinclusion
of ethnic group attenuated any observed socioeconomic
inequalities in the rate of antenatal detection and termination
of pregnancy. The effect of gestational age at detection of
anomaly on termination of pregnancy was also assessed (<17,
18-21, 22-23, >24 weeks’ gestation).
We undertook sensitivity analyses using data on all registered
congenital anomalies to assess whether patterns in outcome of
pregnancy by deprivation for the nine selected anomalies were
similar to those for all registered anomalies.
Results
From 1998 to 2007 there were 1712 separate registrations of
the nine anomalies. We had full information on postcode and
maternal age for 1695 (99%). These 1695 registrations
represented1472fetuseswithoneofthenineselectedanomalies
and107fetuseswithtwoormoreofthenineanomalies,making
1579 fetuses in total (table 1). Antenatal detection rates ranged
from 97% for anencephaly to 77% for diaphragmatic hernia.
Of those antenatally detected, over 80% of fetuses diagnosed
withanencephaly,bilateralrenalagenesis,trisomy13,ortrisomy
18 ended in termination and less than 6% of fetuses with these
anomalies were alive at birth and survived the neonatal period.
Fetuses with diaphragmatic hernia were least likely to be
terminated (24%) but accounted for a quarter of the observed
neonatal deaths relating to the nine anomalies. Just one in five
fetuses with one of the nine selected anomalies were born alive
andsurvivedtheneonatalperiodcomparedwithfouroutoffive
for all other registered anomalies. Of fetuses with an anomaly,
84% (1159) were classified as “white,” with the next largest
ethnic groups being Pakistani (Asian or Asian British) (4%, 53
fetuses), and Indian (Asian or Asian British) (3%, 47 fetuses).
Although birth data were not available by ethnic group, census
data for the register area shows 2% of those aged 0-15 were
classified in the census as Pakistani and 3% as Indian.
Congenital anomalies in utero
Poisson regression models of all anomalies combined showed
a significant increase in the rate of registration of the selected
anomaliesovertime,withrates19%higherin2003-7compared
with 1998-2002 (rate ratio 1.19, 95% confidence interval 1.08
to 1.32; table 2). There was no evidence of a difference in the
overallrateofregistrationsbydeprivation(rateratiocomparing
the most deprived 10th with the least deprived 10th: 1.05, 0.90
to 1.23; table 3), although the rate ratio increased after
adjustment for differences in maternal age (1.22, 1.04 to 1.44).
When we looked at chromosomal and non-chromosomal
anomalies separately, the effect of deprivation differed (table
3), with women from the most deprived 10th at increased risk
of having a fetus with a non-chromosomal anomaly (1.41, 1.17
to 1.70) but at reduced risk of a fetus with a chromosomal
anomaly(0.52,0.39to0.69)comparedwiththosefromtheleast
deprived 10th. This latter effect was predominantly caused by
the differences in maternal age between pregnant women from
themostdeprivedandleastdeprivedareas(25%offetuseswere
carriedbymotherswhowereagedover35inthemostdeprived
10th compared with 64% in the least deprived 10th), and the
increased risk of chromosomal anomalies with increasing
maternalage(womenover35werenearlyfivetimesmorelikely
to carry a fetus with a chromosomal anomaly than younger
mothers(4.96,4.12to5.98)).Incontrast,therewasnoevidence
ofadifferenceintheratesofnon-chromosomalanomalieswith
maternal age (1.01, 0.86 to 1.20). The age adjusted rate ratio
forchromosomalanomaliesshowednoevidenceofadifference
inratesofchromosomalanomalieswithdeprivation(0.85,0.63
to 1.15).
Antenatal detection
In 86% of the affected fetuses the anomaly was detected during
the antenatal period, and there was no evidence that this varied
over time (rate ratio 1.09, 0.98 to 1.21), with deprivation (0.99,
0.84 to 1.17), or with maternal age (0.95, 0.84 to 1.08). A
slightly lower proportion of cases from the most deprived areas
was detected before 22 weeks’ gestation compared with those
from the least deprived areas, though this was not significant
(0.90, 0.74 to 1.08). There was no evidence of a difference in
antenatal detection rates by ethnicity (P=0.913). Antenatal
detectionbytypeofanomalyshowednoevidenceofadifference
in antenatal detection rates with deprivation for either
chromosomal (0.96, 0.70 to 1.31) or non-chromosomal
anomalies (1.00, 0.82 to 1.23) (table 3).
Terminations of pregnancy
Rates of termination of pregnancy in which anomalies were
detected antenatally were substantially lower in the most
deprived 10th (63%) compared with the least deprived 10th
(79%) (rate ratio 0.80, 0.65 to 0.97), and this was similar after
adjustment for differences in maternal age ( 0.79, 0.65 to 0.97).
There was no evidence of a change in the rate of termination
over time (P=0.460) or with maternal age (P=0.968). The rate
of termination was higher among those cases detected early
(75% at <22 weeks’ gestation, 50% at 22-23 weeks, and 19%
at ≥24 weeks), and adjustment for these differences slightly
attenuated the effect of deprivation (0.84, 0.69 to 1.03). Rates
of termination were similar for mothers classified as white
British (71%) or Indian (Asian or Asian British) (71%) but
considerably lower for Pakistani (Asian or Asian British)
mothers (42%). This led to a further small attenuation of the
effect of deprivation (0.86, 0.70 to 1.05). The socioeconomic
differences in rates of termination of pregnancy seen for all
anomaliescombinedweresimilartothoseseenforchromosomal
and non-chromosomal anomalies considered separately (table
3).
Fetal loss, stillbirth, live birth, and neonatal
mortality associated with congenital
anomalies
Rates of live birth associated with an anomaly increased
significantly over time by 27% from 1998-2002 to 2003-7.
Socioeconomic variations in termination of pregnancy for
congenital anomaly impacted greatly on socioeconomic
inequalities in the rate of fetal loss, stillbirth, and live birth
associatedwithananomalyandalsosubsequentneonataldeath.
Considering all anomalies combined, compared with the least
deprived 10th, the most deprived 10th had a 20% higher rate of
stillbirthorfetallosswithananomaly;a61%higherrateoflive
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mortality associated with an anomaly. After adjustment for
differencesinmaternalage,socioeconomicinequalitywidened
for women of a similar age: women in the most deprived 10th
were57%morelikelytohaveafetallossorstillbirth,85%more
likelytohavealivebornbabywithananomaly,and123%more
likely to have a baby with an anomaly who died in the neonatal
period.
Analysisbyindividualtypeofanomalyshowedsignificantwide
socioeconomic inequality for non-chromosomal anomalies.
Compared with the least deprived 10th, rates in the most
deprived 10th were 64% higher for live birth associated with a
non-chromosomal anomaly and 130% higher for neonatal
mortality associated with a non-chromosomal anomaly. In
contrast,socioeconomicinequalityforchromosomalanomalies
seemed narrower and was not significant. In the most deprived
10th, rates of live birth of a baby with a chromosomal anomaly
were 50% higher and rates of neonatal mortality were 44%
higher compared with the least deprived 10th. Adjustment for
the wide differences in maternal age, however, increased the
socioeconomicinequalityforchromosomalanomaliesto121%
increased risk for a live birth of a baby with an anomaly and to
104% for a neonatal mortality associated with an anomaly. For
chromosomal anomalies there was a reduced rate of fetal loss
or stillbirth associated with an anomaly in the most deprived
10th compared with the least deprived 10th, but this was no
longer evident after adjustment for maternal age and seemed to
berelatedtotheincreasedlikelihoodofthepregnanciesofolder
mothers ending in a fetal loss or stillbirth.
Sensitivity analyses
Sensitivity analyses were undertaken to compare the postcode
of residence at antenatal detection with postcode at delivery.
Of the total 1579, this information was available for the 410
fetuses diagnosed antenatally in which the pregnancy did not
end in termination. Thirty three mothers moved residence (8%)
between detection and delivery, and the median 10th of
deprivation for these women was the same for postcode at
antenatal detection and postcode at delivery.
We also carried out sensitivity analyses to compare the pattern
of deprivation with outcome of pregnancy for all 13 580
registered cases of anomaly. This analysis showed a similar
pattern to the nine selected anomalies with a poor prognosis.
There was an increase in the risk of the registration of an
anomalyamongwomenfromthemostdeprivedareas(rateratio
1.25, 1.19 to 1.32) and a substantially lower rate of termination
(0.55, 0.48 to 0.62), resulting in an increased rate of live birth
(1.48, 1.39 to 1.58) and neonatal death (1.98, 1.49 to 2.63)
associated with an anomaly.
Discussion
There are wide socioeconomic differentials in rates of
termination of pregnancy for congenital anomalies that have a
major impact on the observed socioeconomic inequalities in
neonatal mortality. This has been sparsely reported previously
because of a lack of routinely recorded data. While there is no
evidence of a difference in overall rates of registered cases of
the selected nine serious congenital anomalies “in utero,” the
socioeconomicvariationinterminationratesleadstoadoubling
of the rate of neonatal mortality associated with a serious
congenital anomaly in the most deprived areas compared with
theleastdeprivedareas.Also,whilesocioeconomicinequalities
in rates of anomaly in utero varied with type of anomaly,
socioeconomic variations in termination of pregnancy led to a
widening of the socioeconomic inequalities in the rate of live
births and neonatal deaths associated with both chromosomal
andnon-chromosomalanomalies.Weuseddatafromthelargest
of the regional congenital anomaly registers in England.
AlthoughcoverageoftheUKpopulationisincomplete,thedata
held by the nine regional registers are of the highest quality,
and, since the demise of the National Congenital Anomaly
System, are now the only available source of information for
monitoring the incidence of congenital anomalies across the
UK.
Access to services
A decision to continue a pregnancy associated with a serious
congenitalanomalyshouldnotbethoughtofasaflawedchoice
and might relate to societal and cultural norms. It is important,
however, that the reported socioeconomic variations in rates of
termination do not arise from systematic differences in the
delivery of services such as access to timely detection services,
communication of risk of mortality and morbidity by health
professionals, and access to termination of pregnancy. In terms
of timely detection services, we found earlier detection of fetal
anomalies was associated with higher rates of termination of
pregnancy,confirmingworkbyRauchetal.
18WhileinEngland,
Scotland, and Wales there is no gestational age limit at which
a termination of pregnancy can be legally carried out for a
serious fetal anomaly, if this is undertaken in the third trimester
the fetus becomes potentially viable and hence termination at
this stage is more likely to involve feticide and a process that
involves a period of labour. In general, the ethical and
psychologicalacceptabilityofterminationofpregnancyforfetal
anomaly is greater when it is performed earlier in pregnancy,
suggesting that late booking limits a woman’s options in terms
of termination of pregnancy if a serious anomaly is detected.
We found no evidence of variation with socioeconomic
classification or maternal age in the rates in antenatal detection
of anomalies. Rates of early detection, however, were slightly
lower in more deprived areas, leading to a slight attenuation of
the socioeconomic variation in termination rates, suggesting
that this could partially explain the variation. Antenatal care
and screening for fetal anomaly need to be provided in an
accessible way so that inequalities do not arise in the timing of
when parents have to make such difficult decisions about what
to do when faced with the news that their baby has a serious
congenital anomaly. Furthermore, while we refer to “parents”
making decisions, sole registrations of birth are higher among
women from socioeconomically disadvantaged backgrounds.
19
Afterdetectionofananomaly,parentsarereferredtoappropriate
specialists and prenatal counsellors, which might involve
additional investigations such as magnetic resonance imaging
and karyotyping of the fetus and then communication of the
risks of mortality and morbidity associated with the diagnosis.
Socioeconomic differences might exist in health professionals’
communication of these risks and how parents then interpret
that risk. Finding out about a serious anomaly is an extremely
stressful time, and the counselling needs to be unbiased and
respectful of the parents’ choice, culture, religion, and beliefs
20
for them to make an informed decision. Parents need to be
allowedadequatetimeaftercounsellingtoreachtheirinformed
decision. Further research is needed to understand whether
socioeconomic variation in rates of termination arises partially
from socioeconomic differences in the communication and
interpretation of risk and subsequent decision making.
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Cultural and societal factors concerning the acceptability of
congenital anomalies and termination of pregnancy as a
secondary prevention of anomalies are likely to affect the
variations seen here. We did not have information on the
extremely sensitive issue of women’s decision making about
whether to continue the pregnancy. We have shown here that
women of Pakistani (Asian or Asian British) ethnicity have
much lower rates of termination than white British or Indian
(Asian or Asian British) women. We could not look at the
important issues of religious beliefs and the acceptability of
termination of pregnancy, but the ethnic differences seen here
could partially reflect different attitudes to termination with
religion.
21 There is also discord in opinion within groups,
22 and
it is important that ethnicity or religion are not taken as a proxy
for attitudes towards termination of pregnancy. Differences
could be due to variations in the communication of risk and
timing of detection as well as cultural or religious differences
between ethnic groups.
11 23 24
Rates of termination of pregnancy did not vary by maternal age
butvariedwidelybytypeofanomalydetected.Thesevariations
with anomaly probably reflect public understanding and
acceptanceofdifferenttypesofanomaliesandalsothecertainty
of diagnostic information available to clinicians. The high
termination rates for trisomy 13, trisomy 18, anencephaly, and
spina bifida confirm previous research suggesting that women
are more likely to choose a termination if the fetus is affected
bychromosomalanomalies
25oranomaliesofthecentralnervous
system
13 compared with other anomalies of similar severity.
This could reflect a greater clinical certainty around these
diagnoses or that parents believe chromosomal and central
nervoussystemdefectswouldcompromisetheirchild’squality
of life more than other conditions. In contrast, in our study the
ratesofterminationfordiaphragmaticherniawereconsiderably
lowerandyetthisanomalyaccountedforthelargestproportion
of neonatal deaths. This is probably because of the relative
uncertainty about prognosis and less public understanding of
this condition. We found an increase in the registration of
anomalies with a poor prognostic outcome over time. This is
probably related partially to an improved rate of detection of
these conditions and also to improved reporting over time
throughout the region. We found no evidence of an interaction
between time and deprivation, suggesting that this increase in
detection is unlikely to vary by deprivation and hence should
not affect the socioeconomic inequalities reported here.
Limitations
Alternative definitions of anomalies with a poor prognostic
outcome could affect the results seen here. Our sensitivity
analysesofallregisteredcasesofcongenitalanomaly,however,
showed similar findings to the nine selected anomalies. We
focused on those anomalies with a high detection rate through
the fetal anomaly screening programme.
14 The socioeconomic
inequalities in liveborn infants and neonatal deaths might be
lessmarkedforanomaliesthatarenotroutinelydetectedbefore
birth as the differential rates of termination will not play a part.
Other anomalies, such as Down’s syndrome, rely on accessing
additional blood tests and amniocentesis for detection and have
much lower rates of associated mortality and morbidity. Such
conditions might show greater socioeconomic inequalities in
live births associated with an anomaly as there is greater
potential for variation in access to screening and differences in
interpretationofriskand,consequently,anincreasedlikelihood
of socioeconomic differences in decisions to terminate a
pregnancy. Data from antenatal detection through to outcome
of pregnancy are not available nationally in the UK or many
other countries. We have therefore had to focus on a large
populationbasedregisterthatcovers10%ofEnglandandWales.
As we are looking at 10 years of data this is a large population
baseofaround600000birthsandprovidesdetailedinformation
fromantenataldetectionthroughtoinformationonterminations,
birth outcomes, and neonatal mortality unavailable elsewhere.
Ourworklacksdetaileddataonindividualdeprivationmeasures
and so could be open to problems of confounding. Despite this,
provided the results are treated cautiously, our methods are
relatively straightforward and provide a way for data from a
congenital anomaly register to be used to monitor up to date
trends in rates of antenatal detection, termination of pregnancy,
prevalence of live birth, and mortality.
Implications
While this work concentrates on a specific region, we believe
that these results are generalisable to the whole of the UK. The
fetal anomaly screening programme aims to ensure consistent
provisionacrosstheUK,althoughtheremightbesomevariation
between centres in the antenatal detection rates of the selected
anomalies and differences in uptake of screening programmes.
We believe this is unlikely to impact substantially on
socioeconomic differences in behaviour after detection of a
suspectedanomaly.InEngland,Scotland,andWales,secondary
prevention of anomalies through access to termination of
pregnancy isavailable toall.Internationallythis isnotthe case,
but our findings could apply to countries with a similar policy
on termination of pregnancy.
Itisvitalthatvariationsincongenitalanomaliesarisingthrough
the secondary prevention schemes based on screening and the
uptake of termination of pregnancy do not detract from the
importance of reducing inequalities in anomalies through
primarypreventionbeforeconception,ashighlightedbyDolk.
26
Further research into the links between non-chromosomal
anomalies and deprivation needs to be undertaken to identify
primary prevention interventions.
The use of prenatal diagnostic techniques and access to
terminationofpregnancyforfetalanomalyhasreducedneonatal
mortalityinternationally,
6buthereweshowthatthesesecondary
prevention measures have had a knock-on effect of an increase
in the socioeconomic inequality in mortality. Future research
into the reasons underlying the socioeconomic variations in
continuation of pregnancies associated with serious congenital
anomalies should assess whether this is because of systematic
differences in access to services and communication and
interpretation of risk.
We thank members of the NIHR programme grant team: Brad
Manktelow, Elaine Boyle, and Julie Faulkes (University of Leicester) for
helpful advice and comments throughout the study and Shona Golightly
and Anna Springett (Centre for Maternal and Child Enquiries) for help
with information on neonatal and infant deaths. We thank all NHS staff
who notify cases to the EMSYCAR, Rosemary Pridding and Laura Berry
for clerical support, and Martin Perkins for IT support.
Contributors: LKS undertook the statistical analysis and wrote the first
draft of the paper. All authors made substantial contributions to
conception, design, and interpretation of data and contributed to drafting
the article or revising it critically for important intellectual content and
approved the final manuscript. LKS, JLSB, and ESD were responsible
for acquisition of data. LKS is the guarantor.
Funding: This study was funded by UK Department of Health’s National
Institute of Health Research (RM62G0225). EMSYCAR is funded by
the primary care trust in the areas covered by the register. The sponsors
Reprints: http://journals.bmj.com/cgi/reprintform Subscribe: http://resources.bmj.com/bmj/subscribers/how-to-subscribe
BMJ 2011;343:d4306 doi: 10.1136/bmj.d4306 Page 5 of 9
RESEARCHWhat is already known on this topic
Socioeconomic inequalities exist in neonatal mortality
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RESEARCHTables
Table 1| Number of registered cases, antenatal detection rate, and outcome of pregnancy by anomaly 1998-2007. Figures are percentage
(number) except for total cases
Outcome of pregnancy for all cases
Termination in
cases detected
antenatally
Antenatal
detection
Total No of
cases ICD code Neonatal death
Live birth
(surviving >28
days)
Fetal loss and
stillbirth Termination
Selected anomalies:
7 (18) 0 (1) 8 (20) 85 (218) 88 (218) 97 (249) 257 Q000 Anencephaly
2 (8) 22 (75) 6 (20) 70 (235) 78 (235) 90 (303) 339 Q050-Q059 Spina bifida
19 (33) 25 (42) 8 (14) 48 (82) 56 (82) 85 (146) 171 Q234 Hypoplastic left heart
15 (9) 0 (0) 15 (9) 69 (41) 85 (41) 81 (48) 59 Q601/606 Bilateral renal
agenesis
13 (6) 33 (15) 7 (3) 47 (21) 57 (21) 82 (37) 45 Q771-3 Lethal skeletal
dysplasia
23 (43) 47 (86) 8 (14) 22 (40) 29 (40) 77 (140) 183 Q790 Diaphragmatic hernia
4 (10) 34 (77) 15 (34) 47 (109) 56 (109) 85 (195) 230 Q792 Exomphalos
12 (33) 6 (18) 13 (38) 69 (196) 81 (196) 85 (242) 285 Q910-13 Trisomy 18
9 (12) 5 (6) 16 (20) 70 (89) 83 (89) 84 (107) 127 Q914-7 Trisomy 13
Other anomalies audited by fetal anomaly screening programme:
1 (6) 90 (484) 3 (17) 6 (33) — — 540 Q360-Q379 Cleft lip
1 (3) 87 (242) 6 (16) 6 (17) — — 278 Q793 Gastroschisis
10 (160) 20 (317) 10 (158) 60 (944) 70 (944) 86 (1357) 1579 — All selected anomalies
3 (358) 80 (9579) 5 (550) 13 (1514) — — 12 001 — Other registered
4 (518) 73 (9896) 5 (708) 18 (2458) — — 13 580 — Total registered
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RESEARCHTable 2| Rate of pregnancies associated with anomaly, rate of antenatal detection, and outcome of pregnancy by deprivation and year of
birth based on Poisson regression model: all anomalies combined
Change over time adjusted for
deprivation 2003-7 v 1998-2002
Most deprived 10th Least deprived 10th
All selected anomalies (n=1579) 2003-7 1998-2002 2003-7 1998-2002
1.19 (1.08 to 1.32) 30.1 (27.3 to 33.1) 25.2 (22.7 to 27.9) 28.6 (25.7 to 31.9) 24.0 (21.4 to 26.8) Registered cases/10 000 births
1.09 (0.98 to 1.21) 88.8 (80.1 to 98.3) 81.7 (73.1 to 91.4) 89.4 (79.6 to 1.00) 82.3 (72.8 to 93.1) % of all cases detected antenatally
0.95 (0.84 to 1.08) 61.4 (54.1 to 69.6) 64.4 (56.2 to 73.9) 76.9 (67.1 to 88.2) 80.7 (70.0 to 93.0) % terminations in cases detected
antenatally
0.82 (0.60 to 1.13) 2.7 (2.0 to 3.7) 3.2 (2.4 to 4.4) 2.2 (1.5 to 3.2) 2.7 (1.9 to 3.8) Stillbirth or late fetal loss/10 000 births
1.27 (1.06 to 1.52) 12.3 (11.3 to 13.3) 8.9 (7.4 to 10.7) 7.0 (5.7 to 8.6) 5.5 (4.4 to 6.9) Live birth per 10 000/live births
1.08 (0.79 to 1.47) 3.8 (2.9 to 5.1) 3.5 (2.6 to 4.8) 1.9 (1.3 to 2.8) 1.8 (1.2 to 2.6) Neonatal deaths/10 000 live births
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RESEARCHTable 3| Rate of pregnancies associated with anomaly, rate of antenatal detection, and outcome of pregnancy by deprivation adjusted for
year of birth based on Poisson regression model for all anomalies combined and by type of anomaly. Figures are rate ratios for deprivation
gap (most deprived 10th v least deprived 10th), unadjusted or adjusted for maternal age
Chromosomal anomalies (n=461) Non-chromosomal anomalies (n=1118) All selected anomalies (n=1579)
Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted
0.85 (0.63 to 1.15) 0.52 (0.39 to 0.69) 1.43 (1.17 to 1.74) 1.41 (1.17 to 1.70) 1.22 (1.04 to 1.44) 1.05 (0.90 to 1.23) Registered cases/10 000 births
0.97 (0.70 to 1.35) 0.96 (0.70 to 1.31) 1.01 (0.82 to 1.24) 1.00 (0.82 to 1.23) 0.99 (0.84 to 1.18) 0.99 (0.84 to 1.17) % of all cases detected
antenatally
0.82 (0.56 to 1.19) 0.82 (0.57 to 1.17) 0.82 (0.64 to 1.06) 0.84 (0.66 to 1.08) 0.79 (0.64 to 0.98) 0.80 (0.65 to 0.98) % terminations in cases detected
antenatally
0.85 (0.38 to 1.86) 0.47 (0.22 to 1.00) 2.57 (1.26 to 5.24) 2.47 (1.26 to 4.86) 1.57 (0.93 to 2.63) 1.20 (0.74 to 1.97) Stillbirth or fetal loss/10 000 births
2.21 (1.05 to 4.64) 1.50 (0.74 to 3.04) 1.78 (1.28 to 2.48) 1.64 (1.20 to 2.24) 1.85 (1.36 to 2.50) 1.61 (1.21 to 2.15) Live birth/10 000 live births
2.04 (0.81 to 5.14) 1.44 (0.60 to 3.47) 2.32 (1.22 to 4.42) 2.30 (1.25 to 4.23) 2.23 (1.31 to 3.78) 1.98 (1.20 to 3.27) Neonatal deaths/10 000 live births
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